SCHEMBL7209764

SCHEMBL7209764

CN(C)C(=O)[C@H](Cc1ccccc1)NC(=O)C1OC1C(=O)Nc1cccc(C(N)C(=O)OC(C)(C)C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
NTSR1 P30989 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40
MMP14 P50281 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPK1 P28482 1/20 0.40
BACE1 P56817 4/20 0.39
F13A1 P00488 1/20 0.38
TGM2 P21980 1/20 0.38
CAPN1 P07384 2/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
KLK5 Q9Y337 1/20 0.37
PYGL P06737 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7204594 0.91 MMP9 (0.41) MAPTNPSR1TDP1MMP9MMP8
SCHEMBL7202877 0.84 MMP9 (0.41) MAPTTDP1MMP9MMP8MMP14
SCHEMBL7209769 0.84 CCKBR (0.45) MAPTTDP1MMP9MMP8MMP14
SCHEMBL7205316 0.81 MMP9 (0.55) MMP9MMP8MMP14F13A1TGM2
SCHEMBL7205323 0.81 MMP9 (0.55) MMP9MMP8MMP14F13A1TGM2
Hydrochloric Acid SCHEMBL7211691 0.81 MMP9 (0.47) MMP9MMP8MMP14F13A1TGM2
Hydrochloric Acid SCHEMBL7211676 0.81 MMP9 (0.47) MMP9MMP8MMP14F13A1TGM2
SCHEMBL7204598 0.79 MAPT (0.51) MAPTNPSR1TDP1MMP9MMP8
SCHEMBL7204787 0.77 L3MBTL1 (0.43) MAPTTDP1KDM4ECAPN1
SCHEMBL7203208 0.77 CTSS (0.42) MAPTTDP1MMP9KDM4ECAPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0921122-B1 EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL CO LTD (JP) 2003-05-21 EP disclosed
US-6110967-A USEFUL AS AGENTS FOR PREVENTING AND TREATING METABOLIC OSTEOPATHY SUCH AS OSTEOPOROSIS, HYPERCALCEMIA AND BONE METASTASIS OF CANCER BECAUSE THEY SPECIFICALLY INHIBITS CATHEPSIN L AND ITS FAMILY ENZYMES TO INHIBIT BONE RESORPTION TAIHO PHARMACEUTICALS CO., LTD. (JP) 2000-08-29 US disclosed
EP-0921122-A1 NOVEL EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1999-06-09 EP disclosed